Cargando…
Gambogic amide inhibits angiogenesis by suppressing VEGF/VEGFR2 in endothelial cells in a TrkA-independent manner
CONTEXT: Gambogic amide (GA-amide) is a non-peptide molecule that has high affinity for tropomyosin receptor kinase A (TrkA) and possesses robust neurotrophic activity, but its effect on angiogenesis is unclear. OBJECTIVE: The study investigates the antiangiogenic effect of GA-amide on endothelial c...
Autores principales: | Sui, Tongtong, Qiu, Bojun, Qu, Jiaorong, Wang, Yuxin, Ran, Kunnian, Han, Wei, Peng, Xiaozhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592593/ https://www.ncbi.nlm.nih.gov/pubmed/34767490 http://dx.doi.org/10.1080/13880209.2021.1998140 |
Ejemplares similares
-
The tumor-enriched small molecule gambogic amide suppresses glioma by targeting WDR1-dependent cytoskeleton remodeling
por: Qu, Jiaorong, et al.
Publicado: (2023) -
Effects of the selective TrkA agonist gambogic amide on pigmentation and growth of human hair follicles in vitro
por: Campiche, Remo, et al.
Publicado: (2019) -
The selective TrkA agonist, gambogic amide, promotes osteoblastic differentiation and improves fracture healing in mice
por: Johnstone, Maddison R., et al.
Publicado: (2019) -
TrkA Co-Receptors: The Janus Face of TrkA?
por: Trouvilliez, Sarah, et al.
Publicado: (2023) -
NGF Prevents Loss of TrkA/VEGFR2 Cells, and VEGF Isoform Dysregulation in the Retina of Adult Diabetic Rats
por: Fico, Elena, et al.
Publicado: (2022)